Drug-resistant bacteria are "a hidden epidemic"

01/22/2013 | Philadelphia Inquirer, The

Bacteria are quickly becoming resistant to known antibiotics, and few new drugs are being developed to fill the void, experts say. Antibiotics are not as profitable for drugmakers as drugs to treat chronic diseases, so the federal government should develop a system to reward discovery and development of new antibiotics, says infectious disease specialist Jeffrey Jacobson.

View Full Article in:

Philadelphia Inquirer, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA